EUVIMEDOpdag EUVIMED
Crossref

Hematopoietic stem cells activate a latent differentiation pathway to facilitate recovery after 5-fluorouracil-induced myeloablation

Zhen Zhang, Ben Jin, Chenyu You, Ya Li, Li Lin, Jianlong Sun

Developmental Cell · 2026

DOI: 10.1016/j.devcel.2026.02.003 ↗

At a glance

Journal article in Developmental Cell, 2026. Written by Zhen Zhang and 5 co-authors. Institution: School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China. Major MEDLINE topics: Fluorouracil, Hematopoietic Stem Cells, Cell Differentiation, Hematopoiesis. Cited 1 times so far (Crossref); 53 references. Funded by: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Myeloablative chemotherapy induces hematopoietic regeneration, a process orchestrated by hematopoietic stem cells (HSCs). Although prior studies have documented enhanced HSC differentiation during this process, the temporal changes in HSC fate in response to such stress remain unclear. Here, we employed lineage tracing and mathematical modeling to investigate the cell-fate dynamics of Endothelial Protein C Receptor (EPCR)-high HSCs following 5-fluorouracil (5-FU)-induced myeloablation. Our analysis revealed a transient surge in HSC differentiation immediately after 5-FU treatment, generating primarily myeloid-biased multipotent progenitors (MPPs)-subsets that typically receive limited HSC input under steady-state conditions. Following this initial cell-fate switch, elevated HSC differentiation persisted but rapidly reverted to the homeostatic differentiation pattern observed in unperturbed hematopoiesis. Additionally, our data highlight a substantial contribution of MPPs to myeloid and lymphoid lineage regeneration following 5-FU challenge. Together, these findings delineate the sequential fate transitions adopted by HSCs during severe myeloablation and identify stage-specific differentiation patterns of HSCs in stress hematopoiesis.

Subjects

MeSH terms (MEDLINE)

FluorouracilHematopoietic Stem CellsCell DifferentiationHematopoiesisAnimalsCell LineageMiceMice, Inbred C57BL

Author keywords

5-fluorouracilhematopoietic stem celllineage tracingstress hematopoiesis

Substances

Fluorouracil

Authors and institutions

  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China. Electronic address: linli@shanghaitech.edu.cn.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China. Electronic address…

Funding

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China

Cite

APA

Zhang, Z., Jin, B., You, C., Li, Y., Lin, L., & Sun, J. (2026). Hematopoietic stem cells activate a latent differentiation pathway to facilitate recovery after 5-fluorouracil-induced myeloablation. Developmental Cell. https://doi.org/10.1016/j.devcel.2026.02.003

Vancouver

Zhang Z, Jin B, You C, Li Y, Lin L, Sun J. Hematopoietic stem cells activate a latent differentiation pathway to facilitate recovery after 5-fluorouracil-induced myeloablation. Developmental Cell. 2026. doi:10.1016/j.devcel.2026.02.003

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhen and Jin, Ben and You, Chenyu and Li, Ya and Lin, Li and Sun, Jianlong},
  title = {Hematopoietic stem cells activate a latent differentiation pathway to facilitate recovery after 5-fluorouracil-induced myeloablation},
  journal = {Developmental Cell},
  year = {2026},
  doi = {10.1016/j.devcel.2026.02.003}
}
Start for free →